Retraction
Znhit1 inhibits breast cancer by up-regulating PTEN to deactivate the PI3K/Akt/mTOR pathway
Paper Information
Record ID:
38173
Author(s):
Journal:
Publication Date:
March 27, 2019
Retraction Date:
July 13, 2022
(3.4 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (11)
11
Total Citations1
Post-Retraction(9.1%)
10
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
0
After 2+ years
393
Days since retraction (latest)
An Updated Overview on the Synthesis and Anticancer Evaluation of Quinazoline Derivatives
Jasneet Kaur, Sukhmeet Kaur, Amit Ȧnand et al. (6 authors)
ChemistrySelect
Open Access
Published: Aug 2023
13 citations
13 citations
393 days after retraction
Znhit1 Regulates p21<sup>Cip1</sup> to Control Mouse Lens Differentiation
Juan Lü, Jianhong An, Jiawei Wang et al. (10 authors)
Investigative Ophthalmology & Visual Science
Open Access
Published: Apr 2022
5 citations
5 citations
78 days before retraction
The cancer-testis antigen a-kinase anchor protein 3 facilitates breast cancer progression via activation of the PTEN/PI3K/AKT/mTOR signaling
Chuan-Hua Zhan, Dong-Shen Ding, Wei Zhang et al. (6 authors)
Bioengineered
Open Access
Published: Mar 2022
10 citations
10 citations
111 days before retraction
Histopathologic Characteristics of Invasive and Non-invasive Ductal Tumors have Relationship with Different Phenotypes of ER / PR Receptors in Breast Cancer Patients
Rahim Golmohammadi, Mohammad Mohajeri, Alireza Mosavi Jarrahi et al. (6 authors)
Asian Pacific Journal of Cancer Biology
Open Access
Published: Jul 2021
2 citations
2 citations
369 days before retraction
O-linked N-acetylglucosaminyltransferase OGT inhibits diabetic nephropathy by stabilizing histone methyltransferases EZH2 via the HES1/PTEN axis
Na Fang, Ping Li
Life Sciences
Published: Feb 2021
14 citations
14 citations
511 days before retraction
Progesterone receptor membrane component 1 promotes the growth of breast cancers by altering the phosphoproteome and augmenting EGFR/PI3K/AKT signalling
Diego A. Pedroza, Venkatesh Rajamanickam, Ramadevi Subramani et al. (6 authors)
British Journal of Cancer
Open Access
Published: Jul 2020
48 citations
48 citations
720 days before retraction
A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway
Shu Wang, Yingshi Zhang, Tianshu Ren et al. (9 authors)
Cell Death and Disease
Open Access
Published: Jun 2020
27 citations
27 citations
743 days before retraction
Oxidized Low Density Lipoprotein-Induced Atherogenic Response of Human Umbilical Vascular Endothelial Cells (HUVECs) was Protected by Atorvastatin by Regulating miR-26a-5p/Phosphatase and Tensin Homolog (PTEN)
Zhuowen Jia, Liping An, Yanhong Lu et al. (7 authors)
Medical Science Monitor
Open Access
Published: Dec 2019
13 citations
13 citations
934 days before retraction
Gomisin M2 from Baizuan suppresses breast cancer stem cell proliferation in a zebrafish xenograft model
Yeguo Yang, Erwei Hao, Xianglong Pan et al. (9 authors)
Aging
Open Access
Published: Oct 2019
29 citations
29 citations
1003 days before retraction
miR‑425‑5p is associated with poor prognosis in patients with breast cancer and promotes cancer cell progression by targeting PTEN
Sheng Xiao, Hongjia Zhu, Jian Luo et al. (5 authors)
Oncology Reports
Open Access
Published: Oct 2019
35 citations
35 citations
1003 days before retraction
<p>MicroRNA-3651 promotes the growth and invasion of hepatocellular carcinoma cells by targeting PTEN</p>
Xinyang Zhao, Qilong Song, Ge Miao et al. (4 authors)
OncoTargets and Therapy
Open Access
Published: Aug 2019
4 citations
4 citations
1077 days before retraction
Quick Stats
Total Citations:
11
Years Since Retraction:
3.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025